Marksans Pharma Limited (BOM:524404)
India · Delayed Price · Currency is INR 321.25
+0.65 (0.20%)
At close: Aug 21, 2026
Marksans Pharma Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Marksans Pharma stock has a consensus rating of "Strong Buy" and an average price target of ₹324.33. The average 1-year stock price forecast is 0.96% higher than the current stock price, while the lowest is ₹210.00 (-34.63%) and the highest is ₹385.00 (+19.84%).
Price Target: ₹324.33 (+0.96%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Marksans Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 2 | 3 |
| Buy | 0 | 0 | 0 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Financial Forecast
Revenue This Year
35.69B
from 29.51B
Increased by 20.94%
Revenue Next Year
39.96B
from 35.69B
Increased by 11.98%
EPS This Year
12.55
from 9.22
Increased by 36.12%
EPS Next Year
14.07
from 12.55
Increased by 12.09%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.